HCM Q2 2018 Earnings — HUTCHMED (China) Limited Revenue & Financial Results | Market Cap Arena

HCMHUTCHMED (China) Limited

$3B

Q2 2018 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$50M-60.6% YoY

Gross Profit

$15M30.1% margin

Operating Income

-$29M-57.5% margin

Net Income

-$21M-42.0% margin

EPS (Diluted)

$-0.16

QoQ Revenue Growth

-4.7%

Cash Flow

Operating Cash Flow

$12M

Free Cash Flow

$11M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$578M

Total Liabilities

$120M

Stockholders' Equity

$432M

Cash & Equivalents

$75M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$50M	$127M	-60.6%
Gross Profit	$15M	$37M	-59.6%
Operating Income	-$29M	-$16M	-78.4%
Net Income	-$21M	$2M	-1346.2%